Document is current
Any future updates will be listed below
-
Authors
François, Bruno https://orcid.org/0000-0002-2531-1652
Mercier, Emmanuelle
Gonzalez, Céline
Asehnoune, Karim
Nseir, Saad
Fiancette, Maud
Desachy, Arnaud
Plantefève, Gaëtan
Meziani, Ferhat
de Lame, Paul-André
Laterre, Pierre-François
,
Clavel, Marc
Vignon, Philippe
Pichon, Nicolas
Daix, Thomas
Fedou, Anne-Laure
Barraud, Olivier
Nouaille, Michelle
Bourzeix, Paul
Laleu, Séverine
Dequin, Pierre-François
Guillon, Antoine
Ehrmann, Stephan
Garot, Denis
Legras, Annick
Siméon Vieules, Véronique
Mabillat, Christine
Aubrey, Aurélie
Roquilly, Antoine
Cinotti, Raphaël
Mahé, Pierre-Joachim
Demeure, Dominique
Soria, Albane
Flattrès, Delphine
Colin, Gwenhaël
Yehia, Aihem
Lacherade, Jean-Claude
Vinatier, Isabelle
Lebert, Christine
Alcourt, Yolaine
Maguigneau, Natacha
Zinzoni, Vanessa
Fally, Marie-Anne
Robin, Laurence
Pajot, Olivier
Boitrou, Emmanuelle
Favory, Raphaël
Poissy, Julien
Rouze, Anahita
Delcourte, Claire
Rabouel, Yannick
Helms, Julie
Clere-Jehl, Raphaël
Monnier, Alexandra
Merdji, Hamid
Chenaf, Samir
Allam, Hayet
Franja, Vincenta
Wittebole, Xavier
Hantson, Philippe
Colienne, Christine
Gérard, Ludovic
Montiel, Virginie
Castanares Zapatero, Diego
Renard, Suzanne
Dujardin, Marie France
Berghe, Caroline
Gielens, Leslie
- License Information
-
More Information
Article History
Received: 23 February 2018
Accepted: 11 May 2018
First Online: 21 October 2018
Compliance with ethical standards
:
: BF was the coordinating PI for the trial and was appointed as a member of both the study advisory board and the steering committee. PAdL was a consultant to Aridis Pharmaceuticals, Inc. PFL was a member of the advisory board and the steering committee. EM, CG, KA, SN, MF, AD, GP, FM: no conflict of interest to declare.
